secwatch.observer — SEC 8-K summary
======================================

Issuer:     ImmunityBio, Inc. (IBRX)
CIK:        0001326110
Form:       8-K
Filed at:   2025-02-13T23:59:59+00:00
Accession:  0001193125-25-025324
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ImmunityBio approves executive compensation: 2024 bonuses, 2025 equity grants, salary increases
--------------------------------------------------------------------------------

- 2024 cash bonuses paid at 80% of target: Soon-Shiong $372,600, Adcock $477,600, Sachs $230,143; payable March 14, 2025.
- 2025 LTIP RSU grants: Soon-Shiong 822,368, Adcock 822,368, Sachs 246,710; vest ratably over 3 years.
- Option grants at $3.39 strike: Soon-Shiong 2,812,500 NQSO, Adcock 2,812,500 ISO, Sachs 843,750 ISO.
- 2025 base salaries effective March 10: Soon-Shiong $652,050, Adcock $835,800, Sachs $592,619.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326110/000119312525025324/0001193125-25-025324-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326110/000119312525025324/d933627d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-025324

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer